Evidence map›Paper›PMID 30596786›Full record

ArticlePloS one2018

Protective effects of Bacillus probiotics against high-fat diet-induced metabolic disorders in mice.

Bobae Kim, Jeonghyeon Kwon, Min-Seok Kim, Haryung Park, Yosep Ji, Wilhelm Holzapfel, Chang-Kee Hyun

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 84 citations in OpenAlex.

  1. Effect ofNutrients · 2019
    Trial
  2. Article
  3. Article
  4. The correlation between intracystic reflectivity and intraocular inflammation in diabetic macular edema: a novel inflammatory biomarker.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Observational
  5. Ultrasound-assisted extraction of total saponins fromCurrent research in food science · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Impact ofTranslational gastroenterology and hepatology · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Current developments in nutrition · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Bobae KimSchool of Life Science, Handong Global University, Pohang, Gyungbuk, Republic of Korea.
Jeonghyeon KwonSchool of Life Science, Handong Global University, Pohang, Gyungbuk, Republic of Korea.
Min-Seok KimSchool of Life Science, Handong Global University, Pohang, Gyungbuk, Republic of Korea.
Haryung ParkDepartment of Advanced Green Energy and Environment (AGEE), Handong Global University, Pohang, Gyungbuk, Republic of Korea.
Yosep JiDepartment of Advanced Green Energy and Environment (AGEE), Handong Global University, Pohang, Gyungbuk, Republic of Korea.
Wilhelm HolzapfelDepartment of Advanced Green Energy and Environment (AGEE), Handong Global University, Pohang, Gyungbuk, Republic of Korea.
Chang-Kee HyunSchool of Life Science, Handong Global University, Pohang, Gyungbuk, Republic of Korea.ORCID 0000-0003-1862-8739
Handong Global University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, modulation of gut microbiota by probiotics treatment has been emerged as a promising strategy for treatment of metabolic disorders. Apart from lactic acid bacteria, Bacillus species (Bacillus spp.) have also been paid attention as potential probiotics, but nevertheless, the molecular mechanisms for their protective effect against metabolic dysfunction remain to be elucidated. In this study, we demonstrate that a probiotic mixture composed of 5 different Bacillus spp. protects mice from high-fat diet (HFD)-induced obesity, insulin resistance and non-alcoholic fatty liver disease (NAFLD). Probiotic Bacillus treatment substantially attenuated body weight gain and enhanced glucose tolerance by sensitizing insulin action in skeletal muscle and epididymal adipose tissue (EAT) of HFD-fed mice. Bacillus-treated HFD-fed mice also exhibited significantly suppressed chronic inflammation in the liver, EAT and skeletal muscle, which was observed to be associated with reduced HFD-induced intestinal permeability and enhanced adiponectin production. Additionally, Bacillus treatment significantly reversed HFD-induced hepatic steatosis. In Bacillus-treated mice, hepatic expression of lipid oxidative genes was significantly increased, and lipid accumulation in subcutaneous and mesenteric adipose tissues were significantly decreased, commensurate with down-regulated expression of genes involved in lipid uptake and lipogenesis. Although, in Bacillus-treated mice, significant alterations in gut microbiota composition was not observed, the enhanced expression of tight junction-associated proteins showed a possibility of improving gut barrier function by Bacillus treatment. Our findings provide possible explanations how Bacillus probiotics protect diet-induced obese mice against metabolic disorders, identifying the treatment of probiotic Bacillus as a potential therapeutic approach.

Indexed as

BacillusInsulin ResistanceNon-alcoholic Fatty Liver DiseaseObesityAnimalsDietary FatsGene Expression RegulationLipid PeroxidationMaleMiceProbioticsDietary Fats

Identifiers

PMID30596786
PMCPMC6312313
OpenAlexW2907515574

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.